SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OXIGENE INC. (OXGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nikole Wollerstein who wrote (256)9/30/2003 12:04:51 PM
From: schzammm  Read Replies (1) of 273
 
"What an idiotic recomendationes: if CAP4 work OXGN goes too 100 if not too 2"

Your succinct comment concerning CAP4 raises the question, are they just throwing spaghetti on the wall to see if any sticks or does the number of clinical trials give any weight to CAP4 potential? I took a small position on the pullback and have been adding (I must have a genetic defect)including today. If CAP4 works your estimate of 100 might be conservative???
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News